| 2026-04-02 |
详情>>
股本变动：
变动后总股本1461.71万股
|
| 2026-04-02 |
详情>>
业绩披露：
2026年年报每股收益0.28美元,归母净利润406.50万美元,同比去年增长-64.82%
|
| 2026-03-26 |
财报披露：
美东时间 2026-03-26 盘前发布财报
|
| 2026-03-18 |
详情>>
内部人交易：
Siegner Keith R.等共交易9笔
|
| 2025-12-11 |
详情>>
业绩披露：
2026年三季报(累计)每股收益-1.91美元,归母净利润-2804.1万美元,同比去年增长-18.06%
|
| 2025-09-11 |
详情>>
业绩披露：
2026年中报每股收益-1.19美元,归母净利润-1749万美元,同比去年增长7.07%
|
| 2025-06-12 |
详情>>
业绩披露：
2026年一季报每股收益-0.73美元,归母净利润-1084万美元,同比去年增长16.36%
|
| 2025-04-24 |
股东大会：
将于2025-06-10召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To provide advisory approval of the Company’s fiscal 2025 compensation for its named executive officers as disclosed in this Proxy Statement;
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending February 1, 2026;
4.To conduct any and all other business that may properly come before the Annual Meeting or any continuation, postponement, or adjournment thereof.
|
| 2025-04-10 |
详情>>
业绩披露：
2025年年报每股收益0.75美元,归母净利润1155.60万美元,同比去年增长-51.57%
|
| 2025-04-10 |
详情>>
业绩披露：
2023年年报每股收益1.74美元,归母净利润2648.80万美元,同比去年增长-44.22%
|
| 2024-12-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.53美元,归母净利润-2375.1万美元,同比去年增长-234.95%
|
| 2024-12-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.46美元,归母净利润-709.1万美元,同比去年增长-2697.44%
|
| 2024-09-12 |
详情>>
业绩披露：
2025年中报每股收益-1.21美元,归母净利润-1882.1万美元,同比去年增长-296.23%
|
| 2024-06-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.83美元,归母净利润-1296万美元,同比去年增长-214.95%
|
| 2024-04-25 |
股东大会：
将于2024-06-11召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to the Board of Directors to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To provide advisory approval of the Company’s fiscal 2024 compensation for its named executive officers;
3.To approve Amendment No. 2 of the Second Amended and Restated 2017 Equity Incentive Plan that increases the number of shares reserved for issuance thereunder by 1,100,000 shares;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending February 2, 2025;
5.To conduct any and all other business that may properly come before the 2024 Annual Meeting or any continuation, postponement, or adjournment thereof.
|
| 2024-04-11 |
详情>>
业绩披露：
2024年年报每股收益1.55美元,归母净利润2386.10万美元,同比去年增长-9.92%
|
| 2023-04-17 |
股东大会：
将于2023-06-01召开股东大会
会议内容 ▼▲
- 1.To elect eight (8) directors to the Board of Directors to serve until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To provide advisory approval of the Company’s fiscal 2023 compensation for its named executive officers;
3.To approve the Amendment of the Second Amended and Restated 2017 Equity Incentive Plan that increases the number of shares reserved for issuance thereunder by 225,000 shares;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending February 4, 2024;
5.To conduct any and all other business that may properly come before the 2023 Annual Meeting or any continuation, postponement, or adjournment thereof.
|
| 2022-04-18 |
股东大会：
将于2022-06-02召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to the Board of Directors to serve until the 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To provide advisory approval of the Company’s fiscal 2022 compensation for its named executive officers;
3.To provide an advisory vote on the frequency of future stockholder advisory votes on executive compensation;
4.To approve the Second Amended and Restated 2017 Equity Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 550,000 shares;
5.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending January 29, 2023;
6.To conduct any and all other business that may properly come before the 2022 Annual Meeting or any continuation, postponement, or adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-26 |
股东大会：
将于2021-06-07召开股东大会
会议内容 ▼▲
- 1.To elect seven(7) directors to the Board of Directors to serve until the 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve the amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the maximum size of the Company’s Board of Directors to nine(9) directors;
3.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2022;
4.To transact any and all other business that may properly come before the 2021 Annual Meeting or any continuation, postponement, or adjournment thereof.
|
| 2021-04-22 |
复牌提示：
2021-04-22 06:55:33 停牌，复牌日期 2021-04-22 07:20:00
|
| 2020-05-22 |
股东大会：
将于2020-06-04召开股东大会
会议内容 ▼▲
- 1.to elect seven (7) directors to the board of directors to serve until the 2021 Annual Meeting of stockholders and until their successors are duly elected and qualified;
2.to approve the amendment to the Amended and Restated 2017 Equity Incentive Plan that increases the number of shares reserved for issuance thereunder by 690,000 shares;
3.to ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2021;
4.to transact any and all other business that may properly come before the annual meeting or any continuation, postponement, or adjournment thereof.
|
| 2019-05-23 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.to elect seven (7) directors to the board of directors to serve until the 2020 Annual Meeting of stockholders and until their successors are duly elected and qualified;
2.to approve the Amended and Restated 2017 Equity Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 799,823 shares;
3.to ratify the appointment of Marcum LLP as our independent auditor for the fiscal year ending February 2, 2020;
4.to transact any and all other business that may properly come before the annual meeting or any continuation, postponement, or adjournment thereof.
|